Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

The document's conclusion cannot be summarized because the content is not accessible or understandable.

This study found that patients with telogen effluvium who delayed hair washing or collected shed hair were more likely to have higher clinical severity and increased disease-related economic burdens, suggesting these behaviors can aid clinical assessments.

In this study, both Unani formulations tested were effective in managing Telogen Effluvium, with Itrifal Kishneezi and Roghan Amla showing slightly faster early results in reducing hair shedding, although overall efficacy between the two treatments was comparable.

This study observed that telogen effluvium was the most common pattern of diffuse hair loss among 100 female patients, often associated with factors like stress and fever.

This review discusses valproate-associated hair abnormalities, describing their common and benign nature, and outlines management strategies, though new clinical results are not provided.

This study outlines trichodynia, a painful scalp condition often linked with various types of alopecia and psychiatric disorders, noting the absence of specific treatments and highlighting the need for further research on therapeutic options.

This study highlights alopecia areata incognita as a unique form of alopecia areata that shares features with telogen effluvium and may relate to androgenetic alopecia, noting its sudden onset and favorable response to topical steroids.

This study found that vitamin D, vitamin B12, and iron deficiencies, along with thyroid dysfunction, may be associated with telogen effluvium.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

This review describes the diagnosis and management challenges of telogen effluvium, a type of hair loss triggered by physiological stress, and summarizes current understanding of its mechanisms and treatments while recommending future research directions.

This study found that a refined wash test can effectively differentiate shedding hair characteristics among normal individuals, and patients with androgenetic alopecia or telogen effluvium, aiding in diagnosis and monitoring.

This review determined that chronic telogen effluvium lacks a consistent definition and may often be misdiagnosed, as it could represent either early female pattern hair loss or secondary telogen effluvium without identified causes.

This review discusses the complex diagnosis and management of telogen effluvium, noting its high prevalence, psychosocial impact, and need for quantitative diagnostic techniques, but it reports no new research findings.

This study observed that after 12 weeks of using the nutraceutical Alpenta, women with acute or chronic telogen effluvium experienced significant improvements in hair growth parameters, including increased anagen hair percentage, hair density, and diameter, with high patient satisfaction and good product tolerability reported.

The treatment improved hair growth and thickness in most patients with minimal side effects.

Sabal serrulata and biomimetic peptides with microneedling reduced hair loss and improved hair thickness in men with balding.

Female Pattern Hair Loss affects women's quality of life, with limited treatment options and a need for more research.

In this study, oral administration of ginsenoside Rf from Panax ginseng promoted hair regrowth and increased hair thickness in a mouse model of androgenetic alopecia by enhancing androgen receptor degradation, highlighting its potential for cosmetic and functional food applications.

This source explores the causes, diagnosis, and treatments of telogen effluvium, highlighting literature on injection and hardware therapies, including fractional laser therapy, and describes various mechanisms through which physical factors exert therapeutic effects.

This study found that more than 70% of patients with autoimmune blistering diseases experienced alopecia, with about 10% having scarring alopecia, and elevated Dsg1 ratios were linked to hair loss in pemphigus vulgaris.

Male and female mice have different skin thickness, and hormones affect their skin and hair growth differently.

This study suggests that the interaction between folliculin and plakophilin-4 (p0071) may play a role in folliculin's tumor suppressor function by regulating RhoA signaling, impacting cell migration and junction formation.

This study found that telogen effluvium and trichodynia are common in patients after COVID-19, and their severity may be influenced by the severity of the COVID-19 infection.

This study found no clear evidence that finasteride negatively affects erectile function, though it does cause a reduction in ejaculatory volume and has potential implications for prostate cancer risk.

This article emphasizes the need for dermatology to treat gender identity, gender, and sex as distinct factors, aiming to improve patient-specific risk assessment and treatment alignment, and highlights a research gap in distinguishing sex and gender as separate risk factors in the field.

This study demonstrates that dermal white adipose tissue regulates human hair growth and pigmentation through hepatocyte growth factor secretion, highlighting potential therapeutic targets for hair-related disorders.